BRYNJELSEN SEAN (President & CEO) reported 1 transaction at ETON PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/12/2025ACC: 0001437749-25-037741
DirectorOfficer· President & CEO
Since Nov 2018
-6.73K
Net shares
Net seller
$113.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
6.73K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.73K
Price / share
$16.83
Trade value
$113.30K
% of position
0.2%
12/12/2025
2.90M→2.89M
Total
Net shares
−6.73K
Net value
-$113.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2025 | F · Tax Withholding | −6.73K | $16.83 | $113.30K | 0.2% | 2.90M | 2.89M |
| Total | −6.73K | -$113.30K | ||||||
Derivative Transactions0
No derivative transactions reported